Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome

Genes Chromosomes and Cancer

Volumn 50, Issue 6, 2011, Pages 466-477

  Benhammou, Jihane N ^a   Vocke, Cathy D ^a   Santani, Avni ^b   Schmidt, Laura S ^a,c   Baba, Masaya ^a   Seyama, Kuniaki ^d   Wu, Xiaolin ^c   Korolevich, Susana ^c   Nathanson, Katherine L ^e   Stolle, Catherine A ^b   Linehan, W Marston ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c SAIC FREDERICK INC   (United States)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRT HOGG DUBE SYNDROME; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA SEQUENCE; EXON; FLCN GENE; GENE; GENE DELETION; GENE DUPLICATION; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; LUNG CYST; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUS PNEUMOTHORAX;

BIRT-HOGG-DUBE SYNDROME; COMPARATIVE GENOMIC HYBRIDIZATION; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; GERM-LINE MUTATION; HUMANS; KIDNEY NEOPLASMS; MALE; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 79954416358     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20872     Document Type: Article

References (36)

1. Ahvenainen T, Lehtonen HJ, Lehtonen R, Vahteristo P, Aittomaki K, Baynam G, Dommering C, Eng C, Gruber SB, Gronberg H, Harvima R, Herva R, Hietala M, Kujala M, Kääriäinen H, Sunde L, Vierimaa O, Pollard PJ, Tomlinson IP, Björck E, Aaltonen LA, Launonen V. 2008. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: Detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer. Cancer Genet Cytogenet 183: 83-88.
2. Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A, Esposito D, Gillette WK, Hopkins RF III, Hartley JL, Furihata M, Oishi S, Zhen W, Burke TRJr, Linehan WM, Schmidt LS, Zbar B. 2006. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci USA 103: 15552-15557.
3. Birt AR, Hogg GR, Dube WJ. 1977. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113: 1674-1677.
4. Chang YF, Imam JS, Wilkinson MF. 2007. The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 76: 51-74.
5. De La Torre C, Ocampo C, Doval IG, Losada A, Cruces MJ. 1999. Acrochordons are not a component of the Birt-Hogg-Dube syndrome: Does this syndrome exist? Case reports and review of the literature. Am J Dermatopathol 21: 369-374.
6. De Mollerat XJ, Gurrieri F, Morgan CT, Sangiorgi E, Everman DB, Gaspari P, Amiel J, Bamshad MJ, Lyle R, Blouin JL, Allanson JE, Le Marec B, Wilson M, Braverman NE, Radhakrishna U, Delozier-Blanchet C, Abbott A, Elghouzzi V, Antonarakis S, Stevenson RE, Munnich A, Neri G, Schwartz CE. 2003. A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24. Hum Mol Genet 12: 1959-1971.
7. Deininger PL, Batzer MA. 1999. Alu repeats and human disease. Mol Genet Metab 67: 183-193.
8. Drummond C, Grigoris I, Dutta B. 2002. Birt-Hogg-Dube syndrome and multinodular goitre. Australas J Dermatol 43: 301-304.
9. Franke G, Bausch B, Hoffmann MM, Cybulla M, Wilhelm C, Kohlhase J, Scherer G, Neumann HP. 2009. Alu-Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype-phenotype correlations in VHL patients. Hum Mutat 30: 776-786.
10. Hasumi H, Baba M, Hong SB, Hasumi Y, Huang Y, Yao M, Valera VA, Linehan WM, Schmidt LS. 2008. Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene 415: 60-67.
11. Hasumi Y, Baba M, Ajima R, Hasumi H, Valera V, Klein M, Haines D, Merino M, Hong SB, Yamaguchi T, Schmidt LS, Linehan WM. 2009. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci USA 106: 18722-18727.
12. Hattori K, Teranishi J, Stolle C, Yoshida M, Kondo K, Kishida T, Kanno H Baba M, Kubota Y, Yao M. 2006. Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease. Cancer Sci 97: 400-405.
13. Hoebeeck J, van der Luijt R, Poppe B, De SE, Yigit N, Claes K, Zewald R, de Jong GJ. De PA, Speleman F, Vandesompele J. 2005. Rapid detection of VHL exon deletions using real-time quantitative PCR. Lab Invest 85: 24-33.
14. Hu XY, Ray P., Worton RG. 1991. Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J 10: 2471-2477.
15. Inoue K, Osaka H, Thurston VC, Clarke JT, Yoneyama A, Rosenbarker L. Bird TD, Hodes ME, Shaffer LG, Lupski JR. 2002. Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet 71: 838-853.
16. Kunogi M, Kurihara M, Ikegami TS, Kobayashi T, Shindo N, Kumasaka T, Gunji Y, Kikkawa M, Iwakami S, Hino O, Takahashi K, Seyama K. 2010. Clinical and genetic spectrum of Birt-Hogg-Dubé Syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. J Med Genet 47: 281-287.
17. Lee JA, Madrid RE, Sperle K, Ritterson CM, Hobson GM, Garbern J Lupski, JR, Inoue K. 2006. Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann Neurol 59: 398-403.
18. Lehrman MA, Russell DW, Goldstein JL, Brown MS. 1986. Exon-Alu recombination deletes 5 kilobases from the low density lipoprotein receptor gene, producing a null phenotype in familial hypercholesterolemia. Proc Natl Acad Sci USA 83: 3679-3683.
19. Li L, Bray PF. 1993. Homologous recombination among three intragene Alu sequences causes an inversion-deletion resulting in the hereditary bleeding disorder Glanzmann thrombasthenia. Am J Hum Genet 53: 140-149.
20. Lieber MR, Ma Y, Pannicke U, Schwarz K. 2003. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 4: 712-720.
21. Mauillon JL, Michel P, Limacher JM, Latouche JB, Dechelotte P, Charbonnier F, Martin C, Moreau V, Metayer J, Paillot B, Frebourg T. 1996. Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. Cancer Res 56: 5728-5733.
22. McWhinney SR, Pilarski RT, Forrester SR, Schneider MC, Sarquis MM, Dias EP, Eng C. 2004. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J Clin Endocrinol Metab 89: 5694-5699.
23. Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS. 2002. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé Syndrome. Cancer Cell 2: 157-164.
24. Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, Stevens W. 1991. Natural history of thyroid abnormalities: Prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med 91: 363-370.
25. Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloomfield CD, Croce CM. 1994. ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA 91: 6236-6239.
26. Schmidt LS, Warren MB, Nickerson ML, Weirich G, Matrosova V, Toro JR, Turner ML, Duray P, Merino M, Hewitt S, Pavlovich CP, Glenn G, Greenberg CR, Linehan WM, Zbar B. 2001. Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet 69: 876-882.
27. Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM. 2005. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome. Am J Hum Genet 76: 1023-1033.
28. Shchelochkov OA, Cheung SW, Lupski JR. 2010. Genomic and clinical characteristics of microduplications in chromosome 17. Am J Med Genet 152A: 1101-1110.
29. Stankiewicz P, Shaw CJ, Dapper JD, Wakui K, Shaffer LG, Withers M, Elizondo L, Park SS, Lupski JR. 2003. Genome architecture catalyzes nonrecurrent chromosomal rearrangements. Am J Hum Genet 72: 1101-1116.
30. Swensen J, Hoffman M, Skolnick MH, Neuhausen SL. 1997. Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Genet 6: 1513-1517.
31. Takagi Y, Yobayashi T, Shiono M, Wang L, Piao X, Sun G, Zhang D, Abe M, Hagiwara W, Takahashi K. 2008. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (Fnip1/Fnip2) protein. Oncogene 27: 5339-5347.
32. Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B, Linehan WM, Turner ML. 1999. Birt-Hogg-Dube syndrome: A novel marker of kidney neoplasia. Arch Dermatol 135: 1195-1202.
33. Toro JR, Wei M-H, Glenn GM, Weinreich M, Tour O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM. 2008. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: A new series of 50 families and a review of published reports. J Med Genet 45: 321-331.
34. Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM. 2005. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors. J Natl Cancer Inst 97: 931-935.
35. Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS. 2004. Expression of Birt-Hogg-Dube gene mRNA in normal and neoplastic human tissues. Mod Pathol 17: 998-1011.
36. Yap KP, Ang P, Lim IH, Ho GH, Lee AS. 2006. Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing. Clin Genet 70: 80-82.